VMP 17192211000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials
BNF code 1404000X0AAACAC
Virtual Therapeutic Moiety Meningococcal groups A + C + W135 + Y vaccine
Abbreviated name Meningococcal oligosaccharide A, C, W135 and Y conj vacc inj
Basis of preferred name Other
Date of name applicability 1 Jul 2021
Previous name Meningococcal oligosaccharide A, C, W135 and Y vaccine powder and solvent for solution for injection 0.5ml vials
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 0.500
Unit dose form units ml
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Meningococcal group Y oligosaccharide protein conjugate
Virtual Product Ingredient
Ingredient Meningococcal group A oligosaccharide protein conjugate
Virtual Product Ingredient
Ingredient Meningococcal group C oligosaccharide protein conjugate
Virtual Product Ingredient
Ingredient Meningococcal group W135 oligosaccharide protein conjugate
Ontology Drug Form & Route
Form & Route solutioninjection.intramuscular
Dose Form
Formulation Powder and solvent for solution for injection
Drug Route
Route Intramuscular
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Menveo vaccine powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline UK Ltd)
Virtual Medicinal Product Packs
Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback